The persons described in (1) through (9) above are referred to herein as the Reporting
Persons. A list of the directors, executive officers, managers, members and partners, as applicable, of each Reporting Person (collectively, the Covered Persons) is attached hereto as Annex A and is incorporated by reference
herein. To the knowledge of the Reporting Persons, each of the Covered Persons that is a natural person is a United States citizen, except for Elin Strong, who is a citizen of Norway.
The principal business address of each of the Reporting Persons and each associated Covered Person is c/o Athyrium Capital Management, LP, 505 Fifth Avenue,
Floor 18, New York, New York 10017.
(d) During the last five years, none of the Reporting Persons or, to their knowledge, none of the Covered
Persons, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) During the last five years, none
of the Reporting Persons or, to their knowledge, none of the Covered Persons, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
On October 27, 2017, the Company and Co-Invest LP entered into a Series B Preferred Stock Purchase Agreement (the
2017 Series B Stock Purchase Agreement), which provided for the sale of shares of Series B Preferred Stock for an aggregate purchase price of $50.0 million.
On August 27, 2019, the Company and Acquisition LP entered into a Series B Preferred Stock Purchase Agreement pursuant to which Acquisition LP purchased
shares of Series B Preferred Stock for an aggregate purchase price of $25.0 million.
On November 12, 2019, the Company and Acquisition LP
entered into a Series B Stock Preferred Stock Purchase Agreement (the 2019 Series B Stock Purchase Agreement) pursuant to which Acquisition LP purchased additional shares of Series B Preferred Stock for an aggregate purchase price
of $25.0 million. Also on November 12, 2019, Acquisition 2 LP acquired all of the securities of the Company held by Acquisition LP.
On
December 19, 2019 and February 28, 2020, Acquisition 2 LP purchased additional shares of Series B Preferred Stock pursuant to the 2019 Series B Stock Purchase Agreement for an aggregate purchase price of $25.0 million and
$10.0 million, respectively.
On March 31, 2020, Co-Invest LP and the Company entered into the First
Amendment to the Credit Agreement (the Credit Agreement Amendment) providing for the payment in shares of the Companys Series B Preferred Stock of the interest on the amount outstanding under the applicable credit agreement.
On April 3, 2020, the Company and Acquisition 2 LP entered into a Series B Preferred Stock Purchase Agreement pursuant to which Acquisition 2 LP
purchased additional shares of Series B Preferred Stock for an aggregate purchase price of $10.0 million.
On May 8, 2020, the Company and 2020
LP entered into a Note Purchase Agreement pursuant to which 2020 LP purchased an unsecured convertible promissory note (the Convertible Promissory Note) with an annual interest rate of 8.0% and in an aggregate principal amount of
$15.0 million.
In connection with the consummation of the Companys initial public offering of its Common Stock, the Series B Preferred Stock
and the Convertible Promissory Note converted, automatically and without any additional consideration, into 732,794 and 50,000 shares, respectively, of Common Stock. Further, on June 23, 2020, in connection with the initial public offering of
the Companys Common Stock, 2020 LP purchased 133,333 shares of Common Stock. The funds used to purchase such shares were composed of the investment capital of 2020 LP.